Copyright
©The Author(s) 2022.
World J Nephrol. Mar 25, 2022; 11(2): 58-72
Published online Mar 25, 2022. doi: 10.5527/wjn.v11.i2.58
Published online Mar 25, 2022. doi: 10.5527/wjn.v11.i2.58
Table 2 Comparison of characteristics of patients grouped by World Health Organization coronavirus disease 2019 severity
Disease severity | Mild (16/32) | Moderate/severe (16/32) | P value |
Median (IQR) | Median (IQR) | ||
Age (yr) | 77.5 (54.5-84.5) | 75.5 (67.5-78.5) | NS |
Frailty index | 3.5 (2-5) | 3 (2-4.5) | NS |
Co-morbidities | 3 (1-3) | 3 (2-4) | NS |
Men, n (%) | 7 (43.8) | 10 (62.5) | NS |
Women, n (%) | 9 (56.2) | 6 (37.5) | |
Screening, n (%) | 11 (68.8) | 1 (6.3) | < 0.01 |
Symptomatic, n (%) | 5 (31.2) | 15 (93.7) | |
CT infiltrates | NS | ||
0-10% | 13 (86.7) | 11 (68.8) | |
> 10% | 2 (13.3) | 5 (31.2) | |
COVID death, n (%) | 0 (0) | 3 (21.4) | NS |
Non-COVID death, n (%) | 1 (7.1) | 1 (9.1) | NS |
COVID progression, n (%) | 5 (31.3) | 8 (50) | NS |
- Citation: Bacharaki D, Karagiannis M, Sardeli A, Giannakopoulos P, Tziolos NR, Zoi V, Piliouras N, Arkoudis NA, Oikonomopoulos N, Tzannis K, Kavatha D, Antoniadou A, Vlahakos D, Lionaki S. Clinical presentation and outcomes of chronic dialysis patients with COVID-19: A single center experience from Greece . World J Nephrol 2022; 11(2): 58-72
- URL: https://www.wjgnet.com/2220-6124/full/v11/i2/58.htm
- DOI: https://dx.doi.org/10.5527/wjn.v11.i2.58